Essential Medical Supplies Limited 13903286 true 2023-03-01 2024-02-29 2024-02-29 The principal activity of the company is Dental practice activities Digita Accounts Production Advanced 6.30.9574.0 true Mrs S Khanna false 13903286 2023-03-01 2024-02-29 13903286 2024-02-29 13903286 bus:OrdinaryShareClass1 2024-02-29 13903286 bus:OrdinaryShareClass2 2024-02-29 13903286 core:ShareCapital 2024-02-29 13903286 core:CurrentFinancialInstruments 2024-02-29 13903286 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 13903286 bus:FRS102 2023-03-01 2024-02-29 13903286 bus:AuditExempt-NoAccountantsReport 2023-03-01 2024-02-29 13903286 bus:FullAccounts 2023-03-01 2024-02-29 13903286 bus:RegisteredOffice 2023-03-01 2024-02-29 13903286 bus:Director1 2023-03-01 2024-02-29 13903286 bus:OrdinaryShareClass1 2023-03-01 2024-02-29 13903286 bus:OrdinaryShareClass2 2023-03-01 2024-02-29 13903286 bus:EntityHasNeverTraded 2023-03-01 2024-02-29 13903286 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 13903286 countries:AllCountries 2023-03-01 2024-02-29 13903286 core:CostValuation 2023-02-28 13903286 2022-02-09 2023-02-28 13903286 2023-02-28 13903286 bus:OrdinaryShareClass1 2023-02-28 13903286 bus:OrdinaryShareClass2 2023-02-28 13903286 core:ShareCapital 2023-02-28 13903286 core:CurrentFinancialInstruments 2023-02-28 13903286 core:CurrentFinancialInstruments core:WithinOneYear 2023-02-28 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 13903286

Essential Medical Supplies Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 29 February 2024

 

Essential Medical Supplies Limited

Profit and Loss Account for the Year Ended 29 February 2024

The company has not traded during the year. During this year, the company received no income and incurred no expenditure and therefore made neither profit nor loss.

 

Essential Medical Supplies Limited

(Registration number: 13903286)
Balance Sheet as at 29 February 2024

Note

2024
£

2023
£

Fixed assets

 

Investments

3

100

100

Current assets

 

Debtors

4

200

200

Creditors: Amounts falling due within one year

5

(100)

(100)

Net current assets

 

100

100

Net assets

 

200

200

Capital and reserves

 

Called up share capital

6

200

200

Shareholders' funds

 

200

200

For the financial year ending 29 February 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the director on 13 March 2024
 

Mrs S Khanna
Director

   
     
 

Essential Medical Supplies Limited

Notes to the Unaudited Financial Statements for the Year Ended 29 February 2024

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
115 Queen's Rd
Reading
Berkshire
RG1 4DA
UK

These financial statements were authorised for issue by the director on 13 March 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The financial statements are prepared in sterling, which is the functional currency of the company, and rounded to the nearest £.

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.


Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

Essential Medical Supplies Limited

Notes to the Unaudited Financial Statements for the Year Ended 29 February 2024

Creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Investments

2024
£

2023
£

Investments in subsidiaries

100

100

Subsidiaries

£

Cost or valuation

At 1 March 2023

100

Provision

Carrying amount

At 29 February 2024

100

At 28 February 2023

100

4

Debtors

Current

2024
£

2023
£

Other debtors

200

200

 

200

200

5

Creditors

Note

2024
£

2023
£

Due within one year

 

Amounts due to related parties

100

100

 

Essential Medical Supplies Limited

Notes to the Unaudited Financial Statements for the Year Ended 29 February 2024

6

Share capital

Allotted, called up and fully paid shares

 

2024

2023

 

No.

£

No.

£

Ordinary A shares of £1 each

100

100

100

100

Ordinary B shares of £1 each

100

100

100

100

 

200

200

200

200